HENDERSON MICHAEL THOMAS sold SYRE
June 22, 2026 · Form 4 insider transaction
HENDERSON MICHAEL THOMAS sold 20,000 shares of Spyre Therapeutics, Inc. at $100.00 per share, a transaction worth $2.00M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
20,000
Price
$100.00
Total value
$2.00M
InsiderHENDERSON MICHAEL THOMAS
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 22, 2026
Filing dateJune 23, 2026
Shares owned after68,606
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 6, 2026.